搜索临床试验以:Flutemetamol F18 注射液
总计11291个结果
-
Kangpu Biopharmaceuticals, Ltd.完全的
-
University of WashingtonNational Cancer Institute (NCI)终止
-
Millennium Pharmaceuticals, Inc.终止
-
Roswell Park Cancer Institute完全的
-
GE Healthcare完全的
-
GE Healthcarei3 Statprobe终止
-
American College of RadiologyNational Cancer Institute (NCI); American College of Radiology Imaging Network终止
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)招聘中
-
Jonsson Comprehensive Cancer CenterAstraZeneca主动,不招人胶质母细胞瘤 | 复发性胶质母细胞瘤 | 表皮生长因子受体基因突变 | 幕上胶质母细胞瘤 | EGFR基因扩增 | TP53 wt 等位基因美国
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)主动,不招人解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 激素受体阳性乳腺癌 | 转移性乳腺癌美国, 波多黎各, 爱尔兰
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
The First Affiliated Hospital of Xiamen University完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)终止未明确的成人实体瘤,特定方案 | 转移癌 | 肝癌美国
-
National Cancer Institute (NCI)完全的宫颈腺癌 | 宫颈鳞状细胞癌 | IB 期宫颈癌 | IIA期宫颈癌 | IIB期宫颈癌 | III期宫颈癌 | IVA 期宫颈癌 | IVB 期宫颈癌美国
-
Centre Hospitalier Universitaire de Nice未知
-
Barts & The London NHS TrustRoyal Marsden NHS Foundation Trust; Guy's and St Thomas' NHS Foundation Trust; Case Western Reserve... 和其他合作者完全的子宫内膜癌 | 手术分期的子宫内膜癌和宫颈癌 | 宫颈癌:侵袭性疾病,FIGO 1B1 期或更高 | 1A 期伴肌层浸润或任何更高阶段和 3 级 | 1A 期伴有肌层浸润或任何其他更高阶段和浆液性乳头状或透明细胞亚型 | II 期或以上疾病以及任何组织学分级英国
-
Douglas ScharreAvid Radiopharmaceuticals; Mangurian Foundation招聘中
-
Andrei IagaruBoston University; Canary Foundation招聘中
-
Chang Gung Memorial HospitalNational Science Council, Taiwan完全的
-
Centre Antoine Lacassagne招聘中
-
Peking University Cancer Hospital & Institute未知
-
University of California, San Francisco完全的